Three hundred and sixty-seven women presenting to the Breast Unit at Guy's Hospital between 1975 and 1990 whose first distant metastasis was in the skeleton were identified and the influence of a number of patient and tumour characteristics on the development and subsequent prognosis of bone metastases was assessed. One hundred and thirty-nine women had disease that remained clinically confined to the skeleton. They were more likely to be older, with lobular carcinoma and to have presented initially with little or no axillary lymph node involvement. The 228 women who subsequently developed disease at extra-osseus sites were more likely to have poorly differentiated ductal tumours and heavy lymph node involvement at primary diagnosis. On mul...
Introduction: Metastatic lesions to bone carry a poor prognosis. Bone lesions can be responsible for...
Aim: The prognosis for women with breast cancer has improved markedly over recent decades. However, ...
Aim: The prognosis for women with breast cancer has improved markedly over recent decades. However, ...
PURPOSE: Bone is the most frequent site of metastasis among breast cancer patients. We investigated ...
BACKGROUND: Little information is available about the management and clinical outcome of bone metast...
Little information is available about the management and clinical outcome of bone metastases (BM) in...
Little information is available about the management and clinical outcome of bone metastases (BM) in...
BACKGROUND: Little information is available about the management and clinical outcome of bone metast...
Little information is available about the management and clinical outcome of bone metastases (BM) in...
Introduction: Bone is the most frequent site of breast cancer metastasis. Differences between those ...
Background The development of metastases is a negative prognostic parameter for the clinical outcom...
Objective: Bone is the most common site of metastasis in breast cancer. Prognostic factors for predi...
Twenty patients with bone metastasis following surgery for recurrent breast cancer were clinically e...
Background The development of metastases is a negative prognostic parameter for the clinical outcom...
All patients with carcinoma of the breast seen in this Unit since 1970 were reviewed to study the in...
Introduction: Metastatic lesions to bone carry a poor prognosis. Bone lesions can be responsible for...
Aim: The prognosis for women with breast cancer has improved markedly over recent decades. However, ...
Aim: The prognosis for women with breast cancer has improved markedly over recent decades. However, ...
PURPOSE: Bone is the most frequent site of metastasis among breast cancer patients. We investigated ...
BACKGROUND: Little information is available about the management and clinical outcome of bone metast...
Little information is available about the management and clinical outcome of bone metastases (BM) in...
Little information is available about the management and clinical outcome of bone metastases (BM) in...
BACKGROUND: Little information is available about the management and clinical outcome of bone metast...
Little information is available about the management and clinical outcome of bone metastases (BM) in...
Introduction: Bone is the most frequent site of breast cancer metastasis. Differences between those ...
Background The development of metastases is a negative prognostic parameter for the clinical outcom...
Objective: Bone is the most common site of metastasis in breast cancer. Prognostic factors for predi...
Twenty patients with bone metastasis following surgery for recurrent breast cancer were clinically e...
Background The development of metastases is a negative prognostic parameter for the clinical outcom...
All patients with carcinoma of the breast seen in this Unit since 1970 were reviewed to study the in...
Introduction: Metastatic lesions to bone carry a poor prognosis. Bone lesions can be responsible for...
Aim: The prognosis for women with breast cancer has improved markedly over recent decades. However, ...
Aim: The prognosis for women with breast cancer has improved markedly over recent decades. However, ...